The pharmacology and clinical pharmacology of 3, 4-methylenedioxymethamphetamine (MDMA,“ecstasy”) AR Green, AO Mechan, JM Elliott, E O'Shea, MI Colado Pharmacological reviews 55 (3), 463-508, 2003 | 1335 | 2003 |
The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA (ecstasy') E O'shea, R Granados, B Esteban, MI Colado, AR Green Neuropharmacology 37 (7), 919-926, 1998 | 284 | 1998 |
The pharmacology of the acute hyperthermic response that follows administration of 3, 4‐methylenedioxymethamphetamine (MDMA,‘ecstasy’) to rats AO Mechan, B Esteban, E O'Shea, JM Elliott, MI Colado, AR Green British journal of pharmacology 135 (1), 170-180, 2002 | 268 | 2002 |
The hyperthermic and neurotoxic effects of ‘Ecstasy’(MDMA) and 3, 4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype MI Colado, JL Williams, AR Green British journal of pharmacology 115 (7), 1281-1289, 1995 | 227 | 1995 |
In vivo evidence for free radical involvement in the degeneration of rat brain 5‐HT following administration of MDMA (‘ecstasy’) and p‐chloroamphetamine but not … MI Colado, E O'shea, R Granados, TK Murray, AR Green British journal of pharmacology 121 (5), 889-900, 1997 | 221 | 1997 |
5‐HT loss in rat brain following 3, 4‐methylenedioxymethamphetamine (MDMA), p‐chloroamphetamine and fenfluramine administration and effects of … MI Colado, TK Murray, AR Green British journal of pharmacology 108 (3), 583-589, 1993 | 199 | 1993 |
A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response AR Green, E O'shea, MI Colado European journal of pharmacology 500 (1-3), 3-13, 2004 | 195 | 2004 |
A study of the neurotoxic effect of MDMA (‘ecstasy’) on 5‐HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy MI Colado, E O'shea, R Granados, A Misra, TK Murray, AR Green British Journal of Pharmacology 121 (4), 827-833, 1997 | 191 | 1997 |
3, 4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected … B Esteban, E O'Shea, J Camarero, V Sanchez, AR Green, MI Colado Psychopharmacology 154, 251-260, 2001 | 188 | 2001 |
Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function MI Colado, E O’shea, AR Green Psychopharmacology 173, 249-263, 2004 | 183 | 2004 |
A study of the mechanisms involved in the neurotoxic action of 3, 4‐methylenedioxymethamphetamine (MDMA,‘ecstasy’) on dopamine neurones in mouse brain MI Colado, J Camarero, AO Mechan, V Sanchez, B Esteban, JM Elliott, ... British journal of pharmacology 134 (8), 1711-1723, 2001 | 163 | 2001 |
The spin trap reagent α-phenyl-N-tert-butylnitrone prevents ‘ecstasy’-induced neurodegeneration of 5-hydroxytryptamine neurones MI Colado, A Richard European journal of pharmacology 280 (3), 343-346, 1995 | 145 | 1995 |
Neuroprotective effect of aspirin by inhibition of glutamate release after permanent focal cerebral ischaemia in rats J De Cristóbal, MA Moro, A Dávalos, J Castillo, JC Leza, J Camarero, ... Journal of neurochemistry 79 (2), 456-459, 2001 | 139 | 2001 |
Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA (‘ecstasy’) on the 5-HT and dopamine concentrations in mouse brain E O'shea, B Esteban, J Camarero, AR Green, MI Colado Neuropharmacology 40 (1), 65-74, 2001 | 136 | 2001 |
The mechanisms involved in the long‐lasting neuroprotective effect of fluoxetine against MDMA (‘ecstasy’)‐induced degeneration of 5‐HT nerve endings in rat brain V Sanchez, J Camarero, B Esteban, MJ Peter, AR Green, MI Colado British journal of pharmacology 134 (1), 46-57, 2001 | 130 | 2001 |
Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA N Granado, S Ares-Santos, I Oliva, ED Martin, MI Colado, R Moratalla Neurobiology of disease 42 (3), 391-403, 2011 | 126 | 2011 |
Studies on the role of dopamine in the degeneration of 5‐HT nerve endings in the brain of Dark Agouti rats following 3, 4‐methylenedioxymethamphetamine (MDMA or ‘ecstasy … MI Colado, E O'shea, R Granados, B Esteban, AB Martin, AR Green British journal of pharmacology 126 (4), 911-924, 1999 | 119 | 1999 |
Role of hyperthermia in the protective action of clomethiazole against MDMA (‘ecstasy’)‐induced neurodegeneration, comparison with the novel NMDA channel blocker AR‐R15896AR MI Colado, R Granados, E O'Shea, B Esteban, AR Green British journal of pharmacology 124 (3), 479-484, 1998 | 107 | 1998 |
Disruption of blood–brain barrier integrity in postmortem alcoholic brain: preclinical evidence of TLR4 involvement from a binge‐like drinking model A Rubio‐Araiz, F Porcu, M Pérez‐Hernández, MS García‐Gutiérrez, ... Addiction biology 22 (4), 1103-1116, 2017 | 106 | 2017 |
Molecular mechanisms of pain: serotonin1A receptor agonists trigger transactivation by c-fos of the prodynorphin gene in spinal cord neurons JJ Lucas, B Mellström, MI Colado, JR Naranjo Neuron 10 (4), 599-611, 1993 | 105 | 1993 |